- New Purchases: LIAN, BMRN, BLU, ARNA, ISO, ACAD, ZNTL, LUNG, PYXS, SNCE, DICE, MRUS, HYPR, LEGN, EQRX, MDGL, AORT, NVNO, SONX, ITOS, UTRS,
- Added Positions: APLS, CRNX, CCXI, XENE, CHRS, INBX, KOD, AGRX, OMIC, CMAX, NAUT, RPID,
- Reduced Positions: NVTA, IOVA, BBIO, NVRO, GBT, HZNP, MRTX, ISEE, PRCT, RCKT, MGNX, HRMY, CLDX, VBIV, UTHR, ESTA, HCAT, TMCI, SLGC, OM, TYRA, BCAB, PMVP, RXDX, RXDX, TVTX, MORF, CCCC, ACCD, ADMA, ONCR, NUVB, KYMR, IMCR, PNT, RAIN, SRZN, GRPH, ABSI, FUSN, VYNE,
- Sold Out: AVIR, BEAM, DBVT, RNA, NTRA, HCAQ, PODD, CMLTU, ZY, FDMT, TSHA, PSTX, ATEC, RGNX, LSAQ, IMGO, FREQ,
For the details of PERCEPTIVE ADVISORS LLC's stock buys and sells, go to https://www.gurufocus.com/guru/perceptive+advisors+llc/current-portfolio/portfolio
These are the top 5 holdings of PERCEPTIVE ADVISORS LLC- Mirati Therapeutics Inc (MRTX) - 3,283,783 shares, 8.51% of the total portfolio. Shares reduced by 3.07%
- LianBio (LIAN) - 56,319,960 shares, 6.13% of the total portfolio. New Position
- Amicus Therapeutics Inc (FOLD) - 26,559,443 shares, 5.42% of the total portfolio.
- SpringWorks Therapeutics Inc (SWTX) - 4,849,912 shares, 5.31% of the total portfolio.
- Iovance Biotherapeutics Inc (IOVA) - 10,127,941 shares, 3.41% of the total portfolio. Shares reduced by 11.85%
Perceptive Advisors Llc initiated holding in LianBio. The purchase prices were between $6.14 and $16.2, with an estimated average price of $11.42. The stock is now traded at around $4.337300. The impact to a portfolio due to this purchase was 6.13%. The holding were 56,319,960 shares as of 2021-12-31.
New Purchase: Biomarin Pharmaceutical Inc (BMRN)Perceptive Advisors Llc initiated holding in Biomarin Pharmaceutical Inc. The purchase prices were between $71.72 and $91.47, with an estimated average price of $82.84. The stock is now traded at around $91.080000. The impact to a portfolio due to this purchase was 1.84%. The holding were 1,180,000 shares as of 2021-12-31.
New Purchase: BELLUS Health Inc (BLU)Perceptive Advisors Llc initiated holding in BELLUS Health Inc. The purchase prices were between $5.26 and $8.3, with an estimated average price of $6.65. The stock is now traded at around $7.105000. The impact to a portfolio due to this purchase was 1.09%. The holding were 7,645,234 shares as of 2021-12-31.
New Purchase: Arena Pharmaceuticals Inc (ARNA)Perceptive Advisors Llc initiated holding in Arena Pharmaceuticals Inc. The purchase prices were between $49.55 and $92.95, with an estimated average price of $66.26. The stock is now traded at around $93.480000. The impact to a portfolio due to this purchase was 0.82%. The holding were 500,000 shares as of 2021-12-31.
New Purchase: IsoPlexis Corp (ISO)Perceptive Advisors Llc initiated holding in IsoPlexis Corp. The purchase prices were between $4.9 and $15.7, with an estimated average price of $11.07. The stock is now traded at around $6.220000. The impact to a portfolio due to this purchase was 0.66%. The holding were 4,095,498 shares as of 2021-12-31.
New Purchase: ACADIA Pharmaceuticals Inc (ACAD)Perceptive Advisors Llc initiated holding in ACADIA Pharmaceuticals Inc. The purchase prices were between $16.79 and $27.09, with an estimated average price of $20.21. The stock is now traded at around $27.235000. The impact to a portfolio due to this purchase was 0.65%. The holding were 1,584,052 shares as of 2021-12-31.
Added: Apellis Pharmaceuticals Inc (APLS)Perceptive Advisors Llc added to a holding in Apellis Pharmaceuticals Inc by 136.05%. The purchase prices were between $30.74 and $49.16, with an estimated average price of $39.7. The stock is now traded at around $44.520000. The impact to a portfolio due to this purchase was 0.7%. The holding were 1,451,700 shares as of 2021-12-31.
Added: Crinetics Pharmaceuticals Inc (CRNX)Perceptive Advisors Llc added to a holding in Crinetics Pharmaceuticals Inc by 30.28%. The purchase prices were between $19.35 and $28.41, with an estimated average price of $24.78. The stock is now traded at around $19.895000. The impact to a portfolio due to this purchase was 0.6%. The holding were 5,163,517 shares as of 2021-12-31.
Added: ChemoCentryx Inc (CCXI)Perceptive Advisors Llc added to a holding in ChemoCentryx Inc by 157.35%. The purchase prices were between $18.51 and $40.5, with an estimated average price of $35.46. The stock is now traded at around $30.950100. The impact to a portfolio due to this purchase was 0.56%. The holding were 1,415,446 shares as of 2021-12-31.
Added: Agile Therapeutics Inc (AGRX)Perceptive Advisors Llc added to a holding in Agile Therapeutics Inc by 33.76%. The purchase prices were between $0.49 and $0.99, with an estimated average price of $0.7. The stock is now traded at around $0.313000. The impact to a portfolio due to this purchase was 0.05%. The holding were 21,294,485 shares as of 2021-12-31.
Sold Out: Atea Pharmaceuticals Inc (AVIR)Perceptive Advisors Llc sold out a holding in Atea Pharmaceuticals Inc. The sale prices were between $7.67 and $44.59, with an estimated average price of $14.96.
Sold Out: Beam Therapeutics Inc (BEAM)Perceptive Advisors Llc sold out a holding in Beam Therapeutics Inc. The sale prices were between $68.02 and $99.06, with an estimated average price of $85.57.
Sold Out: DBV Technologies SA (DBVT)Perceptive Advisors Llc sold out a holding in DBV Technologies SA. The sale prices were between $1.39 and $5.58, with an estimated average price of $3.33.
Sold Out: Avidity Biosciences Inc (RNA)Perceptive Advisors Llc sold out a holding in Avidity Biosciences Inc. The sale prices were between $20.4 and $28.66, with an estimated average price of $23.92.
Sold Out: Natera Inc (NTRA)Perceptive Advisors Llc sold out a holding in Natera Inc. The sale prices were between $86.26 and $119, with an estimated average price of $103.38.
Sold Out: HealthCor Catalio Acquisition Corp (HCAQ)Perceptive Advisors Llc sold out a holding in HealthCor Catalio Acquisition Corp. The sale prices were between $9.75 and $10.92, with an estimated average price of $9.97.
Here is the complete portfolio of PERCEPTIVE ADVISORS LLC. Also check out:
1. PERCEPTIVE ADVISORS LLC's Undervalued Stocks
2. PERCEPTIVE ADVISORS LLC's Top Growth Companies, and
3. PERCEPTIVE ADVISORS LLC's High Yield stocks
4. Stocks that PERCEPTIVE ADVISORS LLC keeps buying